Expertise in Multi-target(MCMT) Approach
Cutting Edge CMC Technology
AI-Based Bio-Fingerprinting
Microbiome & Metabolomics, Omics
[Press Release] NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01
https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-exclusive-license-agreement-with-mthe...
[Notice] MTHERA enters into MOU with Yuhan (April 2024)
[R&D] MT102: Selected for Scale-up TIPS, Korean Government R&D Funding Program
